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Abstract 
Introduction; It is well established that there is a strong association between Perthes’ 
disease and worsening socioeconomic deprivation. It has been suggested that the 
primary determinant driving this association is exposure to tobacco smoke.  This 
study aimed to examine this hypothesis. 
Method: A hospital case-control study (n=149/146) examined the association 
between tobacco smoke and Perthes’ disease, adjusting for area-level socioeconomic 
deprivation. Tobacco smoke exposure was assessed by parental questionnaire of 
smoking habits during pregnancy, and by quantitative assay of current exposure; 
urinary cotinine-creatinine ratio – a widely used and validated measure of tobacco 
smoke exposure. 
Results: The odds of Perthes’ disease significantly increased with reported in-utero 
exposure after adjustment for socioeconomic deprivation (maternal smoking odds 
ratio (OR) 2.06 (95% CI 1.17 – 3.63), paternal smoking - OR 2.09 (95% CI 1.26 – 
3.46). The cotinine-creatinine ratio was significantly greater in cases (OR 1.63 (1.09 – 
2.43)), suggesting a greater ‘dose’ of current tobacco exposure. 
Conclusion: An association exists between tobacco smoke exposure and Perthes’ 
disease, however we remain unable to disentangle the association with socioeconomic 
deprivation. 
Take Home Message: Perthes’ Disease is associated with tobacco smoke exposure, 
but we are unable to determine if this is causal; it may be the result of residual 
confounding. 
 
 
 
Introduction 
Perthes’ disease is one of the most common diseases presenting to children’s 
orthopaedic surgeons, with a nationwide study suggesting a lifetime incidence of 
approximately 1:8501. Internationally, children of white ancestry and residing at 
higher latitudes have an increased risk of disease2. There is strong evidence of a major 
association with socioeconomic deprivation1,3-7 with disease incidence rates in the 
most deprived communities consistently greater than in the most affluent.  There are 
few other diseases in children with such a strong association with deprivation, yet the 
underlying explanatory determinant remains elusive.  
  
In much of the world, and particularly the UK, a strong association is known to exist 
between socioeconomic deprivation and tobacco smoke exposure8-9. This has led to 
the hypothesis that tobacco smoke may be one explanatory ‘link’ between 
socioeconomic deprivation and Perthes’ disease. This hypothesis was first suggested 
because early studies of Perthes’ disease identified a possible association between low 
birth weight and Perthes’ disease10, and children of smokers were known to have 
significantly reduced birth weights11. There is increasing evidence to suggest that no 
association exists between birth weight and Perthes’ disease12-13, however tobacco 
smoke exposure continues to be of significant aetiological interest as it may exert an 
effect in the early postnatal period. One currently proposed mechanism includes the 
development of tobacco smoke-related vessel wall damage leading to arterial 
infarction in the femoral epiphysis12.  
  
Studies of tobacco smoke exposure are difficult to perform. Parental smoking 
questionnaires are vulnerable to both recall and guilt/concealment bias. An 
alternative, objective means of quantifying tobacco smoke exposure is the 
measurement of cotinine (a metabolite of nicotine) within body fluids (saliva/ serum/ 
urine). Cotinine is a widely used validated, quantitative measure of tobacco smoke 
exposure that offers a ‘snapshot’ of recent tobacco smoke exposure. It has 
demonstrated associations between passive smoking and middle ear infections14, 
asthma15-16 and respiratory syncytial virus17.  Urinary cotinine is non-invasive and 
quantifies tobacco exposure over the previous 3 to 4 days18-20.  
  
This study is the first to begin to quantify the association between environmental 
tobacco smoke and Perthes disease using a parent-reported tobacco smoke exposure 
questionnaire to capture exposure during the life of the child, and urinary cotinine as a 
biological measure of current tobacco smoke exposure.  
  
Methods 
A case-control study was undertaken at a large tertiary referral centre and the sole 
provider of care for children with Perthes’ disease within a wide geographic 
area.  The study was part of a broader study, some of which has been described 
previously21-22. Cases were drawn from a regional Perthes’ register. Cases were aged 5 
– 16 years and were undergoing observation following a diagnosis of Perthes’ disease, 
with exclusions made for multiple epiphyseal dysplasia (MED), cerebral palsy and 
developmental hip dysplasia (DDH) owing to a known independent association with 
avascular necrosis of the hip. No cases were actively being treated with 
immobilisation, and all were at least 4 months following the last surgical intervention, 
to try to ensure that measures of ‘current exposure’ to tobacco smoke were as 
representative as possible of normal exposure.  
  
The protocol for managing Perthes’ disease at the centre, and the justification for this 
approach, is documented elsewhere23. In brief, patients with a marked restriction of 
hip abduction (>20 degrees), undergo surgical containment of the hip, and patients 
without such restriction undergo active observation without the use of any 
immobilisation device.   
  
Controls were an age and sex stratified sample of the orthopaedic outpatient 
population, frequency matched on a 1:1 basis. Frequency matching is a technique to 
match patient characteristics of the groups broadly, rather than trying to match 
patients on a 1:1 basis, this is simpler to perform and the analysis generally becomes 
less complex enabling different statistical techniques (i.e. unconditional regression vs. 
conditional regression). Age matching occurred within 2 groups: 5 – 10 years old, 11 
– 16 years old. Controls were drawn from a number of children’s orthopaedic 
outpatients clinics at the study centre, including knee clinic, general orthopaedic 
clinic, normal variants clinic and trauma clinic. Any controls with a restriction in hip 
movement, unless a clear alternative diagnosis was apparent, were excluded. On each 
sampling day all eligible controls were approached for inclusion. Controls with MED, 
cerebral palsy and DDH were excluded, as were patients actively immobilised 
(irrespective of site of pathology) and those within 4 months of surgery.  
 
We assessed current and in-utero tobacco smoke exposure using two complimentary 
approaches. Firstly, a parental smoking questionnaire was administered which 
included questions from the ‘Environmental Health Surveys in Merseyside’24. This is 
a previously developed questionnaire that details current and prenatal tobacco smoke 
exposure in children. For children actively exposed to tobacco smoke at home, it 
sought an estimate of the quantity of cigarettes consumed per day by the mother and 
father. The questionnaire was completed by whichever parent attended the hospital 
visit with the child. In-utero exposure was determined based on a bivariable response 
(yes/no) to the question “Did the mother/father of the child smoke during this child’s 
pregnancy?” – information for each parent was asked separately. Parents were also 
asked to recall their child’s birthweight.   
  
In addition to the questionnaire, each child was asked to provide a urine sample for 
urinary cotinine measurement. Urine samples were refrigerated immediately after 
donation and frozen within 6 hours at -20 °C. Cotinine was measured on all samples 
en masse using Tandem Mass Spectrometry (TMS). Cotinine values are typically 
expressed as a ratio of the urinary creatinine concentration to overcome any dilutional 
effect.   
  
A measure of deprivation was included in the analysis because deprivation is the only 
consistently reported risk factor for Perthes’ disease. This was assessed using the 
2007 index of multiple deprivation (IMD-2007) score25. The IMD Score is a UK 
national tool for measuring deprivation, which is based upon routinely collected 
national data that is applied to a local geographic area. This is broadly based on seven 
domains of information, namely (1) household income, (2) employment status, (3) 
health deprivation and disability (4) education, skills & training, (5) barriers to 
housing and services (6) crime, and (7) the living environment26. Addresses are 
assigned a score based on their postal code (akin to zip code) which quantifies the 
degree of area deprivation. England and Wales is divided into 34,378 Lower Super 
Output Area (LSOA) with approximately 400 households or 1,500 residents for each 
area. The IMD has undergone several iterations since 2007, but the IMD-2007 was 
the most temporally well-matched version of the score for the period of the study.  
  
This study received research ethical approval (REC-09/H1001/71).  
 
Statistical Analysis  
Analysis was conducted using bivariable analyses, and then a multivariable model. 
Logistic regression analysis was conducted adjusting for age at the time of the study 
as a continuous variable and sex.  Adjustment for socioeconomic deprivation was 
made within a separate logistic model based on the area deprivation score derived 
from the postcode. All data analysis was conducted using Stata 10 (Statacorp, College 
Station, TX, USA).  
  
The distribution of urinary cotinine-creatinine ratio (CCR) was positively skewed, and 
a log transformation was used for analyses. P values less than 0.05 (two tailed) were 
considered statistically significant.  
  
 
 
Results 
Two hundred and ninety five individuals participated (149 cases and 146 controls). 
63% percent (149 of 235 individuals) of cases approached agreed to participate. There 
was no difference in the age and sex distribution of non-participants, but they were 
typically from more deprived areas compared to participants based upon postcode 
deprivation score (Case IMD Score 31.62 (95% CI 28.3 – 34.9), Controls IMD Score 
37.6 (95% CI 34.1 – 41.1), non-participants IMD Score 46.9 (95% CI 41.1 – 52.8)). 
The demographic composition of cases and controls is illustrated in table 1. The 
composition of controls by region of pathology and the nature of the aetiology 
(trauma/ elective) is also detailed. 
 
Table 1 - Characteristics of the study population.  
Measure Cases Controls P-value 
Demographics    
Age, years. (95% CI) 10.7 (10.1 – 11.2) 11.2 (10.7 – 11.7) 0.2 
Sex (M:F) 
 
4.1: 1 4.8: 1 0.6 
Side of Disease    
Right 67 (45%) - - 
Left 57 (38%) - - 
Bilateral 
 
25 (17%) - - 
Time Since Diagnosis  
(95% CI) 
 
4.7 years (4.1 – 
5.29) 
- - 
Source of Control Population   
Trauma Patients - 49 (33%) - 
Anterior Knee Pain - 35 (24%) - 
Physiological Foot 
Deformities  
- 35 (24%) - 
‘General Orthopaedic’ 
 
- 27 (18%) - 
 
 
The smoking questionnaire was omitted or only partially completed in 7 individuals 
(4 cases and 3 controls). Cotinine was available in 139 cases and 135 controls. One 
sample (case) leaked prior to analysis and was therefore unavailable. The remainder 
of children declined to donate a sample. One child (14-years-old) was a notable 
outlier with a cotinine level of 4845 μg/L (laboratory qualitative guides define an 
active heavy smoker >2500 μg/L27) and was therefore excluded. Urinary cotinine 
(>5μg/L) was detected in 54% of children whose parents reported home tobacco 
exposure, and 9% of children whose parents denied exposure. The cotinine-creatinine 
ratio correlated closely with self-reported cigarette smoke exposure in the mother 
(p<0.001), but not the father (p=0.20) - see Table 2.  
  
 
 
 
Table 2 – Relationship between reported tobacco exposure and cotinine-
creatinine ratio. 
Self Reported 
Smoke Exposure 
(Cigarettes per 
day) 
Mean Cotinine-Creatinine Ratio (g/mmol) 
Cases Controls Overall 
Mother Father Mother Father Mother Father 
0 0.8 0.8 1.1 1.1 1.0 1.0  
0 – 10 6.7 12.7 0.8 6.1 3.4 9.7 
10 – 20 9.12 7.0 1.1 0.9 6.0 4.7 
> 20 11.8 1.7 8.1 1.2 10.4 1.5 
  
  
Bivariable analysis (Table 3) revealed an association between Perthes’ disease and 
self-reported paternal tobacco smoking in pregnancy. Maternal smoking showed a 
similar association, though this failed to reach statistical significance. There was no 
difference in current self-reported tobacco smoke exposure between cases and 
controls. The number of children with detectable cotinine within the urine was not 
significantly different between cases and controls, although the cotinine-creatinine 
ratio was significantly higher amongst cases (Table 3, Figure 1).  
  
 
 
  
 
 
 
 
 
 
 
 
 
 
Table 3 – Bivariable analysis of tobacco smoke exposure. 
Characteristic Number of Individuals (% of total) P-value 
Cases (n=149) Controls (n=146) 
    
Self Reported 
Questionnaire * 
   
Current Smoke Exposure       
Any Smoking at Home 61 (42%) 51 (36%) 0.27 
        
Mother (cigarettes per day)     0.22 
0 99 (66%) 110 (75%)   
0 – 10 7 (5%) 9 (6%)   
10 – 20 21 (14%) 13 (9%)   
> 20 22 (15%) 14 (10%)   
        
Father (cigarettes per day)     0.28 
0 85 (57%) 98 (67 %)   
0 – 10 22 (15%) 19 (13%)   
10 – 20 26 (17%) 16 (11%)   
> 20 16 (11%) 13 (9%)   
        
In-Utero Exposure       
Paternal Smoking in 
Pregnancy 
67 (46%) 47 (32%) 0.02 
Maternal Smoking in 
Pregnancy 
47 (32%) 22 (23%) 0.07 
        
Cotinine Assay       
Detected, >5μg/L 38 (27.3%) 37 (27.4%) 0.93 
Log (Cotinine-Creatinine 
Ratio, g/mmol (95% CI) 
1.36 (0.87 – 1.85) 0.51 (0.61 – 0.97) 0.01 
  
  
*as a percentage of individuals completing question. Part completed in 4 cases and 3 
controls.  
  
 
Figure 1 - Cotinine-creatinine ratio amongst cases and controls  
  
Adjustment for area deprivation strengthened the association with reported current 
tobacco smoke exposure. The risk of Perthes’ disease was greater in those reporting 
higher levels of tobacco smoke exposure (dose-response) (Table 4).  Tobacco use by 
either the mother or father in pregnancy was associated with an increased risk of 
Perthes’ disease, the magnitude and significance of which strengthened after 
adjustment for deprivation.   
 
The proportion of individuals with detectable urinary cotinine did not differ between 
cases or controls, even after adjustment for deprivation. However, the magnitude of 
cotinine (cotinine-creatinine ratio) detected was significantly greater in cases, 
suggesting greater current exposure to tobacco smoke.   
  
Table 4 – Multivariable model of cigarette smoke exposure. 
Exposure  Odds Ratio with adjustment for deprivation 
(95% Confidence Interval) 
  Unadjusted Adjusted for area 
deprivation 
  
Self Reported Questionnaire      
Current Smoke Exposure     
Any Smoking at Home 1.35 (0.84 – 2.18) 1.71* (1.02 – 2.86)   
        
Mother (cigarettes per day)       
0 1 (Ref) 1 (Ref)   
1 – 10 0.86 (0.31 – 2.41) 0.80 (0.28 – 2.30)   
10 – 20 1.86 (0.88 – 3.93) 2.73* (1.23 – 6.06)   
> 20 1.84 (0.89 – 3.83) 2.79* (1.26 – 6.16)   
        
Father (cigarettes per day)       
0 1 (Ref) 1 (Ref)   
1 – 10 1.41 (0.71 – 2.80) 1.75 (0.86 – 3.57)   
10 – 20 1.95 (0.98 – 3.90) 2.62* (1.26 – 5.46)   
> 20 1.36 (0.62 – 3.01) 1.73 (0.76 – 3.95)   
        
Maternal Smoking 
in Pregnancy 
1.62 (0.96 – 2.74) 2.06* (1.17 – 3.63)   
Paternal Smoking 
in Pregnancy 
1.76* (1.09 - 2.85) 2.09* (1.26 – 3.46)   
        
Cotinine Measures     
Cotinine (>5μg/L) Detected 
(Yes/ No) 
0.98 (0.58 – 1.68) 1.19 (0.68 – 2.08)   
Log [Cotinine-Creatinine 
Ratio (g/mmol)] 
1.56 (1.07 – 2.27)* 1.63 (1.09 – 2.43)*     
  
 All are adjusted for current age and sex. 
* indicates statistical significance (p<0.05) 
Area - adjustment for IMD-2007 
  
Birth History 
There was no evidence that those affected with Perthes’ disease (cases) or controls 
differed in terms of birth weight or prematurity (Table 5). However, as expected there 
was a significant negative association between birth weight and maternal smoking 
during pregnancy (p=0.002) and paternal smoking during pregnancy (p=0.04).  
  
Table 5 - Birth weight and prematurity 
Measure Mean (95% CI) 
Cases Controls P 
Mean Birth Weight, Kg 3.4 (3.3 – 3.4) 3.4 (3.3 – 3.5) 0.98 
Percentage of Premature 
Individuals  (<37 weeks) 
8.7 (5.2 - 14.3) 10.2 (6.4 – 16.3) 0.65 
  
  
Discussion 
This study adds support to an increasing body of literature identifying an association 
between tobacco smoke and Perthes’ disease 12,28-29. For the first time, this study used 
a biologically validated questionnaire to demonstrate an association with tobacco 
smoke. No association was identified between Perthes’ disease and either birth weight 
or prematurity. 
  
The ideal means by which to investigate the effects of tobacco exposure would be a 
prospectively collected and biologically validated exposure assay. This would include 
sampling from the prenatal period through birth and until disease onset. However, 
such data is unavailable. Parental recall of smoking habits, and biological assays of 
current tobacco exposure are the best-available methods by which to quantify 
exposure in this population.  
  
The most robust evidence for an association between Perthes' and tobacco smoke 
comes from a large case control study within the Swedish inpatient register, with 
linkage to prospectively acquired maternal smoking data12. This study eliminated 
recall bias by collecting data prior to disease onset, and adjusted for socioeconomic 
deprivation (by occupational category), demonstrating a dose-response relationship 
with a greater risk of Perthes’ disease corresponding to a greater degree of maternal 
tobacco smoke exposure (1-9 cigarettes, OR 1.36 (95% CI 1.10 – 1.68). >10 
cigarettes, OR 2.02 (95% CI 1.59 – 2.58). These results are very supportive of the 
association, with a similar magnitude and direction of association to that 
demonstrated within this study. 
  
The proportion of children with detectable urinary cotinine was no different between 
the two groups, though the ‘tobacco dose’ (as measured using both the questionnaire 
and cotinine-creatinine ratio) was significantly greater amongst cases. The increased 
risk of Perthes’ disease with ‘high dose’ exposure gives credibility to the observed 
association being influential in the disease aetiology – in terms of Hill’s criteria for 
causation30. However, a key difficulty in establishing a causal association is the 
absence of an accepted and plausible biological mechanism by which tobacco smoke 
exposure might initiate Perthes’ disease. The most commonly proposed mechanism, 
with biological and clinical plausibility, is that Perthes’ disease develops as the result 
of an arterial infarction. Bahmanyar et al. hypothesised that smoking may precipitate 
Perthes’ disease through vessel wall damage, similar to other forms of vascular 
disease12. Bahmanyar et al. demonstrated that young adults who had Perthes’ disease 
in infancy also had an increased risk of cardiovascular disease in adulthood31.  
 
Given the association between tobacco use and low birth weight, it appears 
contradictory that smoking during the antenatal period may predispose to Perthes’ 
disease, yet children with Perthes’ disease do not appear to have a reduced birth 
weight. This may therefore suggest that tobacco smoke exerts an effect in the post-
natal period.  
  
Understanding the relationship between disease and tobacco smoke exposure can be 
difficult owing to confounding, bias (recall bias and guilt/ concealment bias) and 
recall error. Confounding is one of the most difficult factors to overcome, owing to 
the shared strong associations of both Perthes’ disease and tobacco smoke with 
deprivation 6,9,32. The effects of smoking were strengthened after adjusting for 
socioeconomic deprivation. Studies often poorly adjust for deprivation, and it is 
unclear if the observed association is merely a proxy marker of unmeasured 
deprivation. Criticism may be made of the use of an area measure of deprivation 
rather than an individual deprivation measure, with the potential for ecological errors 
introduced by area assumption. However measures of individual deprivation 
introduce other difficulties that are overcome by area IMD, such as categorical data 
with few categories, and coding difficulties perpetuated by subjective occupation 
titles 33-34.    
  
Recall bias and guilt bias are both important considerations when examining the 
association with tobacco smoke. The use of a hospital control group may partially 
control for such biases as both groups have children who have, or are perceived to 
have, a ‘disease’, and therefore recall bias is likely to be a non-differential 
misclassification bias. The extent to which this was controlled is 
unquantifiable. Recall error is a further important consideration, particularly when 
asking individuals to recall details of a period (i.e. pregnancy), which may have 
occurred many years ago. Previous studies have demonstrated that maternal smoking 
recall is still high many years after pregnancy. Studies from the Netherlands and 
Cardiff demonstrated very good agreement (kappa of 0.77 and 0.80 respectively) 
between a dichotomised response (yes/no) to a question regarding tobacco exposure 
in pregnancy, at up to 10 years after birth when compared to data prospectively 
collected during pregnancy 35-36. Similarly, parental recall of birth weight up to 16 
years after birth has been demonstrated to be a good measure in epidemiology, with 
studies suggesting 75%-90% accuracy within 8oz (227g) 35-38. There may be a modest 
reduction in accuracy in those of lower social educational attainment, however even 
in manual workers the overall accuracy remains >75%. This therefore suggests that 
parental recall is sufficient to identify large differences in birth weight or tobacco 
smoke exposure in pregnancy between cases and controls.  
  
This study, like previous studies, has demonstrated that the urinary cotinine-creatinine 
ratio is more closely correlated with maternal, rather than paternal tobacco use39. 
Within this study 54% of children whose parents reported home tobacco use tested 
positive for cotinine, and only 9% of those who did not report home tobacco use 
tested positive. Detectable cotinine in children without a history of home exposure 
may reflect exposure from another caregiver, a peer or active cigarette smoking in the 
child. Likewise, undetectable cotinine levels in children whose parents reported 
smoking may reflect, for instance, an environment in which smoking at home only 
occurred outdoors. Only one child had a disproportionately elevated cotinine-
creatinine ratio consistent with active smoking.  
  
Conclusion 
This study has demonstrated an association between Perthes disease and tobacco 
smoke using a biologically validated smoking questionnaire. The greatest risk of 
Perthes’ disease appeared in those with the greatest exposure to tobacco smoke. 
Exposure in the early life of the child appeared to have a stronger association than 
with current tobacco smoke exposure, which supports suggestions that the key disease 
determinant acts early in the development of the child. We remain unable to ensure 
that the association is not the result of residual confounding, and the biological 
plausibility of the association remains unclear. 
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